Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inovio Pharma (INO)

Inovio Pharma (INO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 824,713
  • Shares Outstanding, K 210,386
  • Annual Sales, $ 7,410 K
  • Annual Income, $ -166,410 K
  • 60-Month Beta 0.49
  • Price/Sales 119.85
  • Price/Cash Flow N/A
  • Price/Book 1.90
Trade INO with:

Options Overview Details

View History
  • Implied Volatility 114.15% ( -1.99%)
  • Historical Volatility 57.56%
  • IV Percentile 57%
  • IV Rank 38.67%
  • IV High 232.56% on 11/03/21
  • IV Low 39.51% on 10/05/21
  • Put/Call Vol Ratio 0.46
  • Today's Volume 4,988
  • Volume Avg (30-Day) 4,976
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 126,366
  • Open Int (30-Day) 113,141

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate -0.33
  • Number of Estimates 5
  • High Estimate -0.27
  • Low Estimate -0.37
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -135.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.80 unch
on 01/24/22
6.04 -37.09%
on 12/27/21
-2.28 (-37.50%)
since 12/23/21
3-Month
3.80 unch
on 01/24/22
7.77 -51.09%
on 11/26/21
-2.94 (-43.62%)
since 10/22/21
52-Week
3.80 unch
on 01/24/22
19.00 -80.00%
on 02/02/21
-5.20 (-57.78%)
since 01/22/21

Most Recent Stories

More News
First Week of March 18th Options Trading For Inovio Pharmaceuticals

Investors in Inovio Pharmaceuticals Inc. saw new options become available this week, for the March 18th expiration.

INO : 3.80 (-3.06%)
Growing Acceptance Of Digital Health Services is a Huge Boon for Healthcare Cloud Computing Market

Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Cloud computing increases real-time data collection and improves accessibility to the data. It has outpaced the conventional...

CSCO : 57.03 (+0.62%)
IBM : 128.50 (-0.66%)
HCTI : 1.5200 (-2.25%)
INO : 3.80 (-3.06%)
TRHC : 13.99 (+1.89%)
HCAT : 29.57 (-2.99%)
PHR : 30.85 (-0.48%)
INO March 4th Options Begin Trading

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the March 4th expiration.

INO : 3.80 (-3.06%)
Down 21.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Inovio (INO)

The heavy selling pressure might have exhausted for Inovio (INO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising...

INO : 3.80 (-3.06%)
Better Vaccine Stock: Ocugen vs. Inovio Pharmaceuticals

Both companies could become notable latecomers in the coronavirus vaccine market.

OCGN : 3.21 (-2.13%)
INO : 3.80 (-3.06%)
INO January 2022 Options Begin Trading

Investors in Inovio Pharmaceuticals Inc. saw new options become available today, for the January 2022 expiration.

INO : 3.80 (-3.06%)
Inovio Pharmaceuticals (INO) Reports Q3 Loss, Tops Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of 12.12% and 53.68%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

INO : 3.80 (-3.06%)
Inovio: Q3 Earnings Snapshot

PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Tuesday reported a third-quarter loss of $60.2 million, after reporting a profit in the same period a year earlier.

INO : 3.80 (-3.06%)
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases

FN Media Group Presents USA News Group News Commentary   Vancouver, BC –November 9, 2021 – USA News Group  –  After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing...

BLMH.CN : 0.385 (+20.31%)
QGEN : 48.60 (-0.18%)
INO : 3.80 (-3.06%)
NVAX : 78.30 (-7.50%)
BNTX : 141.07 (-4.36%)
Analysts Estimate Inovio Pharmaceuticals (INO) to Report a Decline in Earnings: What to Look Out for

Inovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

INO : 3.80 (-3.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled...

See More

Key Turning Points

3rd Resistance Point 4.62
2nd Resistance Point 4.48
1st Resistance Point 4.20
Last Price 3.80
1st Support Level 3.78
2nd Support Level 3.64
3rd Support Level 3.36

See More

52-Week High 19.00
Fibonacci 61.8% 13.19
Fibonacci 50% 11.40
Fibonacci 38.2% 9.61
Last Price 3.80
52-Week Low 3.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar